Peroxisome proliferator-activated receptor-gamma activation inhibits tumor progression in non-small-cell lung cancer. - Wikidata - awgldk - TriplyDB

Peroxisome proliferator-activated receptor-gamma activation inhibits tumor progression in non-small-cell lung cancer.

Peroxisome proliferator-activated receptor-gamma activation inhibits tumor progression in non-small-cell lung cancer.

http://www.wikidata.org/entity/Q40601264

about

Prostacyclin inhibits non-small cell lung cancer growth by a frizzled 9-dependent pathway that is blocked by secreted frizzled-related protein 1 The pathophysiological function of peroxisome proliferator-activated receptor-gamma in lung-related diseases.Lung cancer chemoprevention: current status and future prospects PPARγ as a Novel Therapeutic Target in Lung Cancer The non-genomic crosstalk between PPAR-gamma ligands and ERK1/2 in cancer cell lines Proline oxidase, a proapoptotic gene, is induced by troglitazone: evidence for both peroxisome proliferator-activated receptor gamma-dependent and -independent mechanisms Dynamic network of transcription and pathway crosstalk to reveal molecular mechanism of MGd-treated human lung cancer cells Peroxisome proliferator-activated receptor-gamma activation inhibits tumor metastasis by antagonizing Smad3-mediated epithelial-mesenchymal transition The investigation of mitogen-activated protein kinase phosphatase-1 as a potential pharmacological target in non-small cell lung carcinomas, assisted by non-invasive molecular imaging Minireview: Familiar Faces in Unfamiliar Places: The Emerging Role of Nuclear Receptors in Lung Cancer Peroxisome proliferator-activated receptor-gamma inhibits transformed growth of non-small cell lung cancer cells through selective suppression of Snail Enhancement of docetaxel anticancer activity by a novel diindolylmethane compound in human non-small cell lung cancer Cyclooxygenases and lipoxygenases in cancer.The phosphatidylinositol-3-kinase inhibitor PX-866 overcomes resistance to the epidermal growth factor receptor inhibitor gefitinib in A-549 human non-small cell lung cancer xenografts PPAR-gamma activation inhibits angiogenesis by blocking ELR+CXC chemokine production in non-small cell lung cancer Anticancer actions of PPARγ ligands: Current state and future perspectives in human lung cancer Epigenetic effects and molecular mechanisms of tumorigenesis induced by cigarette smoke: an overview Pleomorphic liposarcoma: clinical observations and molecular variables.PPARγ Promotes Growth and Invasion of Thyroid Cancer Cells Peroxisome proliferator activated receptor γ protein expression is asymmetrically distributed in primary lung tumor and metastatic to lung osteosarcoma samples and does not correlate with gene methylation.PPARgamma: a novel molecular target in lung disease.The role of peroxisome proliferator-activated receptors in pulmonary vascular disease.Xenobiotic-metabolizing cytochromes P450 in ontogeny: evolving perspective.Emerging PPARγ-Independent Role of PPARγ Ligands in Lung Diseases.Research resource: Diagnostic and therapeutic potential of nuclear receptor expression in lung cancer.Regulatory role of KEAP1 and NRF2 in PPARγ expression and chemoresistance in human non-small-cell lung carcinoma cells.Anti- and Protumorigenic Effects of PPARγ in Lung Cancer Progression: A Double-Edged Sword Chemoprevention of lung cancer: concepts and strategies.AT7867 Inhibits Human Colorectal Cancer Cells via AKT-Dependent and AKT-Independent Mechanisms.The toxicology of ligands for peroxisome proliferator-activated receptors (PPAR).Function of PPARgamma and its ligands in lung cancer.Stimulatory Effects of Peroxisome Proliferator-Activated Receptor-gamma on Fcgamma Receptor-Mediated Phagocytosis by Alveolar Macrophages.Peroxisome proliferator-activated receptors in lung cancer.Pioglitazone is as effective as dexamethasone in a cockroach allergen-induced murine model of asthma The potential of antidiabetic thiazolidinediones for anticancer therapy.Chemotherapeutic drugs induce PPAR-gamma expression and show sequence-specific synergy with PPAR-gamma ligands in inhibition of non-small cell lung cancer Activation and Molecular Targets of Peroxisome Proliferator-Activated Receptor-gamma Ligands in Lung Cancer.The functional significance of nuclear receptor acetylation Present concepts and future outlook: function of peroxisome proliferator-activated receptors (PPARs) for pathogenesis, progression, and therapy of cancer.Activated PPARgamma Targets Surface and Intracellular Signals That Inhibit the Proliferation of Lung Carcinoma Cells.

P2860

Q24303556-809834E2-861D-44AA-ABC7-DE53F0ABCC12 Q24814517-309458E9-1E71-4A64-8EAB-A78F19976885 Q26995495-4DC5CD6B-8654-4449-908D-639C0EFBA6C7 Q28068114-ADF55B65-7F08-4A15-B9D7-6160BCB87B27 Q28238709-A2076AC0-1D02-40C8-AFD6-694B0B63CA02 Q28283135-98F13CE9-E506-4A33-B1CA-88EDD15D00EF Q28484052-3B33B383-AB25-4364-86C8-7C079E0D97ED Q30498249-AC07373A-298F-4D25-A81C-A36EAB4F8CF1 Q33540291-CCC3C7CC-C042-4D2A-906C-824720FAF893 Q33631471-9DBC3DF0-4FA7-4150-8AF6-7F31D824D53C Q33727031-3E246449-F559-4728-BF42-D67F09504A0D Q33837550-7EEF3C18-D138-4449-B6E3-9225E23CA8E5 Q34224752-000F41B2-4CE5-4900-85D3-CF8C80DB2904 Q34524510-8E98A7FF-D278-40FE-BD93-5C643A9C6B0B Q34768343-F62535BB-D8D5-47DC-A2C5-2E7A8034850B Q34878637-B1CF0E89-2A92-426D-99AB-9405846DF837 Q34928808-56E40D2D-CE78-44D7-8F2A-AD5130443630 Q35179511-0F9AAB69-7447-4CCD-B1C9-2F2354BF3638 Q35608757-C6749A18-AA33-42F0-BDF3-21ED0FECBDD3 Q35763145-E361779C-FE09-422B-A0A8-8D981DE525E8 Q35805954-A8110B2B-32D5-45E8-A7DA-B4AA5E1A1619 Q35925357-7093FB35-3EC1-4BA8-9DD3-76D6B2689A6E Q35956157-5E20C2DC-A5C0-4FF7-95D0-5FBA0D6E6728 Q36063833-C44F5733-240B-475A-992A-946C207222A9 Q36113804-53310F40-FEAF-4492-AB1D-24CA891F3DFD Q36162095-807905AE-A166-4800-ADDC-E55698D1C8DC Q36183887-6D67ED95-EF59-4058-A195-9D43754A366B Q36185641-6D070541-CE74-45F3-83D1-4A33D3C03A11 Q36247749-02586A87-4A1C-44C7-9B7C-A89965A128BA Q36328530-BAFFE387-F174-4788-82D1-6DB524ED7A92 Q36414175-540CE286-3734-4EEF-88DD-9C4BFAEEE01E Q36417564-92415807-8C54-4D48-A6C3-337AF7D52636 Q36417658-AF3F391B-3B89-4B09-9DC9-22D4F9B4FC92 Q36440045-A1F6DBB4-F74B-4380-991D-2BC318D721FD Q36568732-BC93E57D-72C7-4177-919D-641E7FA354AE Q36661722-9913C6D1-DFCF-4F19-A84B-3C7079C52DF5 Q36676421-1A759D1C-3E92-405C-89DB-BC55B7F6F7AE Q36732771-4447E529-DB1E-48BD-B789-D4F1FA1E4E3B Q36795404-20B20F55-35C7-4400-9A94-F87F39FED58A Q36836697-9609A582-F14A-4EB3-A6C0-86AA9FB94154

P2860

Peroxisome proliferator-activated receptor-gamma activation inhibits tumor progression in non-small-cell lung cancer.

http://www.wikidata.org/entity/Q40601264

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

Peroxisome proliferator-activa ...... in non-small-cell lung cancer.

@en

type

label

Peroxisome proliferator-activa ...... in non-small-cell lung cancer.

@en

prefLabel

Peroxisome proliferator-activa ...... in non-small-cell lung cancer.

@en

P1433

Q40601264-E0A7BAD3-E256-456E-9BC0-D7A3BC960D39

P1476

Q40601264-E0325CB9-A23E-45CF-875F-90FC748D1082

P2093

Q40601264-29A540DF-90A1-4FE7-9612-1E807450C01B

Q40601264-735020D2-7DA2-4296-9653-DEFAD6AB0894

Q40601264-8A29212C-868A-4116-8142-12DF4520330D

Q40601264-9259B5BA-A6A8-40A4-83B2-8ECFDCF45016

Q40601264-A197EB4B-E875-4A73-A7A4-73E447EA093B

Q40601264-BAD4B18A-0FB0-4F5F-B580-0787145BAAD8

P2860

Q40601264-02E3961E-09CD-4B84-B19B-1989D3260436

Q40601264-0D648514-20CE-4390-A5A3-ECF6021E110D

Q40601264-2A942096-33A7-4D72-A000-600576A5B2F1

Q40601264-4F5ECF2B-B6DE-4738-B1D5-CBF880FA32B6

Q40601264-653E6691-6644-4E0B-A36A-89F8830377FD

Q40601264-7B6D2E7C-156F-4AE1-9C98-FBCF6AFCC958

Q40601264-89A99E50-53AD-497F-ABCA-465C9237DF5A

Q40601264-9CB87DDD-2C79-41E3-B3A7-017DD95FD863

Q40601264-C544E10B-95AF-4A3E-B8EF-FAA7C9657354

Q40601264-CAF5443B-BF69-4B27-9A66-0D7B8D289CDA

P2888

Q40601264-9660F246-1C92-468F-8230-E3E4BAC9ED8F

P304

Q40601264-3D1CDE4C-38A2-4A48-865A-D923A2B54C26

P31

Q40601264-BFA3587F-B7CC-45F8-9BAE-4B7C5E6B86D6

P356

Q40601264-2E05A78C-6849-4290-B4A6-CCB2DAA12108

P407

Q40601264-046F7441-D6C4-4A5D-95FF-45903EA448A1

P433

Q40601264-62214C4C-DECD-46D7-A093-01E8BB1FE8BD

P478

Q40601264-703852FE-651D-4108-9DE1-E3F885D38004

P50

Q40601264-B1CD7939-D39B-47C1-A85D-63AC62A6CDDA

P577

Q40601264-B513B8AA-2D31-42AE-8FF3-72A0E94E26B8

P5875

Q40601264-F5FF969E-C343-447B-B282-57B738734F63

P6179

Q40601264-855F11D4-31AA-4F02-89C8-B479932AF294

P698

Q40601264-6F6AC17E-B922-4991-BAF7-4F16B277AFC5

P356

P1433

P1476

Peroxisome proliferator-activa ...... in non-small-cell lung cancer

@en

P2093

Binju Joel

http://www.w3.org/2001/XMLSchema#string

Douglas A Arenberg

http://www.w3.org/2001/XMLSchema#string

Gregory P Kalemkerian

http://www.w3.org/2001/XMLSchema#string

Raju C Reddy

http://www.w3.org/2001/XMLSchema#string

Theodore J Standiford

http://www.w3.org/2001/XMLSchema#string

Victor J Thannickal

http://www.w3.org/2001/XMLSchema#string

P2860

The peroxisome proliferator-activated receptor delta, an integrator of transcriptional repression and nuclear receptor signaling.

PPARgamma ligands inhibit primary tumor growth and metastasis by inhibiting angiogenesis

Mechanism of 17-beta-estradiol-induced Erk1/2 activation in breast cancer cells. A role for HER2 AND PKC-delta

The mechanisms of action of PPARs

Ligands for peroxisome proliferator-activated receptorgamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice

Retinoic acid induces proteasome-dependent degradation of retinoic acid receptor alpha (RARalpha) and oncogenic RARalpha fusion proteins.

Proteasome-dependent degradation of the human estrogen receptor.

Hyperexpression of mitogen-activated protein kinase in human breast cancer.

Activated Raf-1 causes growth arrest in human small cell lung cancer cells

Subtype- and response element-dependent differences in transactivation by peroxisome proliferator-activated receptors alpha and gamma.

P2888

P304

100-108

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.ONC.1206885

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P50

Venkateshwar G Keshamouni

P577

2004-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8928817

http://www.w3.org/2001/XMLSchema#string

P6179

1035035633

http://www.w3.org/2001/XMLSchema#string

P698

14712215

http://www.w3.org/2001/XMLSchema#string